May 30 - 31, 2012
Current situation & expected future development of Generic Licensing Activities

According to a December 2011 report by The Economist, blockbuster drugs worth 130 billions of euros in global annual sales will go off-patent by 2015, thus posing a great opportunity for the generic industry. At the same time, as the pricing pressures and consolidation on the European market continues, generic companies are looking more and more on the emerging markets, and focusing on differentiation.

With this being said, it now seems to be the perfect time to bring industry minds together to exploit best practices in tackling the most challenging regulatory, pricing and IP issues of today’s business development and licensing activities. Aiming to guarantee your excellence in deal making and expanding into today’s most attractive markets, we introduce to you our 6th Annual Licensing in Generics.

HOT TOPICS TO BE PRESENTED

Understand the current market trends in the global generic business development and licensing – situation and future development on the EU and global market
Exploit the opportunities in rising markets for generic licensing activities – case studies from Russia, India, China, the Middle East, and Brazil
Hear about the key regulatory developments influencing the business of generic companies in the EU, USA and India

Venue

Sorry, this event is quite new so we couldn't find any venue information.
Please check again in the near future.

Related events

Annual Licensing in Generics May 30 - 31, 2012